After completing this activity, participants will be better equipped to discuss the major difficulties in managing MDR HIV and to illustrate the promise of both existing and forthcoming MDR HIV medicines.

The survey examined the methods used by payors to collect and monitor social determinants of health (SDOH), their high-priority disease states, the measures they feel are necessary to address disparities, how they believe those measures will affect how people access and use medications, and their ongoing and future efforts in this area.

Sufentanil sublingual tablet 30 mcg (Dsuvia, AcelRx), an effective novel tablet formulation of the synthetic opioid sufentanil, has been given FDA approval for the management of severe acute pain in adult patients in licensed medically supervised healthcare settings. The medication is administered sublingually in a single-dose, prefilled applicator.

Although many organizations advise reducing the range of antibiotic therapy for hospitalized patients in light of laboratory findings, some are challenging the validity of the practice. One expert argued that there are insufficiently strong data on spectrum de-escalation to determine whether it improves outcomes.

These recommendations “attempt to provide practical guidance for clinicians and patients regarding the use of nonstatin therapies to further reduce ASCVD risk in situations not covered by the guideline until such time as the scientific evidence base expands.”

Mental health care professionals who prescribe or dispense to patients need to know the half-lives of the drugs that they prescribe, the half-lives of active metabolites — if any — how these half-lives may differ with individual patient characteristics, and how to use this knowledge to prescribe to best advantage.